Clinical Trials Browser

INDUSTRY × Triple Negative Breast Neoplasms × seviteronel × Clear all

NCT02580448 2019-02-01

CLARITY-01

Phase 1/2 Completed

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms